
This invitation-only event is an intimate and informal afternoon featuring rapid-fire pitches by the RM industry’s cutting-edge, early-stage companies, a panel of leading venture capitalists with interest in the space and a talk by one of the field’s top researchers.
The S&T Committee serves as a forum for Alliance members to exchange ideas, information, and data on different science and technology issues within the regenerative medicine field.
This committee is responsible for formal interaction with Congress, congressional staff, and federal agencies including testifying, attending meetings, and other activities as appropriate.
The Regulatory Committee is responsible for interaction with regulatory agencies at public hearings, meetings, roundtables, PDUFA negotiations, submission of comments to the regulatory docket, and other forums for public discussion
The Communication and Education Committee is responsible for overseeing the Alliance’s communications activities, including interaction with the media and public education.
This committee works closely with the investment community while also advocating for federal and state policies that promote capital formation in regenerative medicine.
Join over 600 expected international delegates for ISCT’s 19th Annual Meeting in Auckland, New Zealand including MD and/or PhD clinicians and scientists, industry personnel from cell therapy or enabling technology companies and regulatory professionals.
Presentations from FDA and Leading Experts